Characterisation of protease activity during SARS-CoV-2 infection identifies novel viral cleavage sites and cellular targets with therapeutic potential (2020)
Attributed to:
Advanced MS instrumentation for enhanced proteomics capabilities
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.09.16.297945
Publication URI: http://dx.doi.org/10.1101/2020.09.16.297945
Type: Preprint